Related Experiment Video

Updated: Jan 2, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.0K

Downregulation of SRPK2 promotes cell cycle arrest though E2F1 in non-small cell lung cancer

Xin Li1, Shaoyu Yang, Minna Zhang

  • 1Department of Oncology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou. XinLidgh@163.com.

European Journal of Histochemistry : EJH
|December 14, 2019
PubMed

Insights

Serine-arginine protein kinase 2 (SRPK2) is elevated in non-small cell lung cancer (NSCLC), driving tumor growth and progression. Targeting SRPK2 may offer a new therapeutic strategy for NSCLC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Serine-arginine protein kinases (SRPKs) regulate cell cycle and pre-mRNA splicing.
  • The role of SRPKs, particularly SRPK2, in non-small cell lung cancer (NSCLC) remains largely unexplored.
  • SR proteins are crucial for RNA splicing and are implicated in various cancers.

Purpose of the Study:

  • To investigate the role and potential therapeutic significance of SRPK2 in non-small cell lung cancer (NSCLC).
  • To determine the expression levels of SRPK2 in NSCLC tissues and correlate them with patient survival.
  • To elucidate the mechanism by which SRPK2 influences NSCLC cell proliferation and cell cycle progression.

Main Methods:

  • Quantitative analysis of SRPK2 expression in NSCLC tissues versus normal tissues.
  • Kaplan-Meier survival analysis to correlate SRPK2 expression with patient outcomes.
  • In vitro studies involving SRPK2 overexpression and knockdown in NSCLC cell lines to assess proliferation and cell cycle.
  • Investigation of SRPK2's effect on SC35 phosphorylation and E2F1 transcriptional activity.
  • In vivo xenograft models to evaluate SRPK2's impact on tumor growth.

Main Results:

  • SRPK2 expression was significantly upregulated in NSCLC tissues compared to adjacent normal tissues.
  • High SRPK2 expression correlated with shorter overall survival in NSCLC patients.
  • SRPK2 overexpression promoted NSCLC cell proliferation and cell cycle progression, while its knockdown inhibited these processes.
  • SRPK2 was found to phosphorylate SC35, which in turn activated E2F1-mediated transcription of cell cycle-related genes, promoting tumor growth in vivo.

Conclusions:

  • SRPK2 plays a critical role in promoting NSCLC progression by regulating cell cycle progression through SC35 and E2F1.
  • SRPK2 represents a potential therapeutic target for the clinical treatment of non-small cell lung cancer.
  • Understanding SRPK2's function provides insights into NSCLC pathogenesis and offers avenues for novel therapeutic strategies.

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.2K
Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

6.8K

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K